(Q29011686)

https://doi.org/10.1016%2FS0264-410X%2896%2900286-1

23 March 2017

author name string

Elie Shlyakhov

series ordinal

1

1 reference

https://doi.org/10.1016%2FS0264-410X%2896%2900286-1

23 March 2017

Ethan Rubinstein

series ordinal

2

1 reference

https://doi.org/10.1016%2FS0264-410X%2896%2900286-1

23 March 2017

Ilya Novikov

series ordinal

3

1 reference

https://doi.org/10.1016%2FS0264-410X%2896%2900286-1

23 March 2017

language of work or name

English

0 references

publication date

April 1997

1 reference

https://doi.org/10.1016%2FS0264-410X%2896%2900286-1

23 March 2017

1 reference

https://doi.org/10.1016%2FS0264-410X%2896%2900286-1

23 March 2017

volume

15

1 reference

https://doi.org/10.1016%2FS0264-410X%2896%2900286-1

23 March 2017

issue

6-7

1 reference

https://doi.org/10.1016%2FS0264-410X%2896%2900286-1

23 March 2017

page(s)

631-636

1 reference

https://doi.org/10.1016%2FS0264-410X%2896%2900286-1

Human live anthrax vaccine in the former USSR.

23 March 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900286-1

7 January 2021

Anthrax vaccines: past, present and future

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900286-1

7 January 2021

Recent advances in the development of an improved, human anthrax vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900286-1

7 January 2021

Biochemical and physiological changes induced by anthrax lethal toxin in J774 macrophage-like cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900286-1

7 January 2021

Antibodies to anthrax toxin in humans and guinea pigs and their relevance to protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900286-1

7 January 2021

Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900286-1

7 January 2021

Efficacy of a standard human anthrax vaccine against Bacillus anthracis spore challenge in guinea-pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900286-1

7 January 2021

Bacterial vaccines: old and new, veterinary and medical

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900286-1

7 January 2021

Bacillus anthracis protective antigen, expressed in Salmonella typhimurium SL 3261, affords protection against anthrax spore challenge.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900286-1

7 January 2021

Anthrax: virulence and vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900286-1

7 January 2021

Resistance to the Sterne strain of B. anthracis: phagocytic cell responses of resistant and susceptible mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900286-1

7 January 2021

Pathogenesis and genetic control of resistance to the Sterne strain of Bacillus anthracis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900286-1

7 January 2021

Characterization of macrophage sensitivity and resistance to anthrax lethal toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900286-1

7 January 2021